Search

Your search keyword '"Boston Scientific Corp. -- Product development"' showing total 44 results
Start Over Descriptor "Boston Scientific Corp. -- Product development" Search Limiters Available in Library Collection
44 results on '"Boston Scientific Corp. -- Product development"'

1. Recent Findings in Peripheral Artery Disease Described by Researchers from Boston Scientific (Diversity In Clinical Trial Inclusion for Peripheral Artery Disease Lower Extremity Endovascular Interventions: a Systematic)

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiovascular diseases, Health
Abstract

2024 MAR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Researchers detail new data in Cardiovascular Diseases and Conditions - Peripheral Artery Disease. According to [...]

Published
2024

2. MEP Aids Medical Device Manufacturers: Many medical device companies have benefitted from the Hollings Manufacturing Extension Partnership

Author

Sprovieri, John

Subjects
Johnson & Johnson -- Product development, Boston Scientific Corp. -- Product development, Medical equipment -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Physiological apparatus -- Product development, Pharmaceutical industry -- Product development, Business, Engineering and manufacturing industries
Abstract

Bringing a medical device to market is a daunting prospect for even the largest manufacturers. There's nurturing a concept from prototype to finished product; determining how and where to manufacture [...]

Published
2018

3. A Boost in Hope for Stroke Treatment

Author

Watanabe, Myrna E.

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Health aspects, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Stroke (Disease) -- Drug therapy, Health
Abstract

Recent developments and recommendations could mean that better treatment and improvements in procedures are on the way for people who arrive in emergency rooms (ERs) in the midst of a [...]

Published
2005

4. Second drug-coated stent heats up cardiovascular market

Author

Hitchens, Kathy

Subjects
Boston Scientific Corp. -- Product development, Taxus Express2 (Medical instrument) -- Licensing, certification and accreditation, Medical equipment -- Licensing, certification and accreditation, Physiological apparatus -- Licensing, certification and accreditation, Medical equipment and supplies industry -- Product development
Abstract

Move over, Cypher! There's a new drug-eluting stent in the cardiac catheterization suites. During its first year of competition with Cypher (Cordis Corp./ Johnson & Johnson) in Europe, it relegated [...]

Published
2004

5. Second medicated stent props open arteries

Subjects
Boston Scientific Corp. -- Product development, United States. Food and Drug Administration -- Licensing, certification and accreditation, Stent (Surgery) -- Licensing, certification and accreditation, Medical equipment and supplies industry -- Product development
Abstract

A second medicated stent has been approved by the FDA. It's Boston Scientific Corp.'s Taxus Express Stent System. Coated with paclitaxel, the stent is designed to prop open arteries after [...]

Published
2004

6. Late News; FDA OKs 2nd drug-eluting stent

Subjects
Company legal issue, Health care industry, Boston Scientific Corp. -- Product development, OhioHealth -- Cases, HealthSouth Corp. -- Officials and employees, Physicians -- Cases, Health care industry -- Cases, Health care industry -- Officials and employees, Stent (Surgery) -- Product development, Medical equipment and supplies industry -- Product development
Abstract

The Food and Drug Administration gave Boston Scientific Corp.'s Taxus drug-eluting stent the go-ahead for U.S. marketing, creating the first rival in the U.S. to Johnson & Johnson's Cypher stent, [...]

Published
2004

9. Stroke Prevention Device Misses Key Goal in Study

Subjects
Boston Scientific Corp. -- Product development, Stroke (Disease) -- Prevention -- Analysis, Medical test kit industry -- Product development -- Analysis, Medical equipment and supplies industry -- Product development -- Analysis, Cardiovascular equipment -- Analysis -- Product development, General interest, News, opinion and commentary
Abstract

SAN FRANCISCO (AP) -- The future is unclear for a heart device aimed at preventing strokes in people at high risk of them because of an irregular heartbeat. Early results [...]

Published
2013

10. Single-use ureteroscope yields high-quality images

Author

Krader, Cheryl Guttman

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Fiber optics -- Equipment and supplies, Business, Health care industry
Abstract

London -- Findings from preclinical studies evaluating the performance of an investigational single-use digital flexible ureteroscope (Lithovue, Boston Scientific) support it as a viable alternative to current non-disposable flexible digital [...]

Published
2015

11. Food and drug administration approves Bard E-Luminexx vascular stent, Boston Scientific premounted stent system

Author

Geller, Jay

Subjects
C.R. Bard Inc. (Murray Hill, New Jersey) -- Product development, Boston Scientific Corp. -- Product development, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Stent (Surgery) -- Licensing, certification and accreditation, Business, Health care industry, E-Luminexx (Medical instrument) -- Licensing, certification and accreditation
Published
2009

12. Some much-needed good news for Boston scientific's stents

Subjects
Boston Scientific Corp. -- Product development, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Stent (Surgery) -- Licensing, certification and accreditation, Business, Health care industry
Published
2005

15. A rare but troubling side effect

Author

Heuser, Stephen

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Complications and side effects -- Product development, Medical test kit industry -- Product development, Blood clot -- Causes of -- Risk factors -- Complications and side effects, Thrombosis -- Causes of -- Risk factors -- Complications and side effects, Medical equipment and supplies industry -- Product development, Business, General interest, Business, regional
Abstract

Byline: Stephen Heuser Sep. 18--The product is one of the biggest-selling medical devices in history. The side effect is rare and deadly. And the impact is a giant question mark [...]

Published
2006

16. Boston Scientific says data support a heart treatment

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Prosthesis -- Product development, Implants, Artificial -- Product development, Medical equipment and supplies industry -- Product development
Abstract

Boston Scientific, the medical device maker, released data yesterday indicating that an experimental device to treat clogged arteries was more effective than current treatments available in the United States. Boston […]

Published
2002

17. New Pre-Trial Research Findings from O. Dudeck and Co-Researchers Reported (Safety and Efficacy of Target Vessel Catheterization with the New Steerable Microcatheter Direxion Compared with a Standard Microcatheter: A Prospective, Preclinical ...)

Subjects
Boston Scientific Corp. -- Product development, Catheterization -- Comparative analysis, Medical test kit industry -- Standards -- Product development -- Comparative analysis, Medical equipment and supplies industry -- Standards -- Product development -- Comparative analysis, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- Current study results on Clinical Trials and Studies have been published. According to news reporting out of Magdeburg, Germany, [...]

Published
2014

18. Findings from Boston Scientific Corporation in Clinical Trials and Studies Reported

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- A new study on Clinical Research is now available. According to news reporting originating from Natick, Massachusetts, by NewsRx [...]

Published
2014

19. Largest Randomized Clinical Trial Of Implantable Cardioverter Defibrillator Recipients Demonstrates Excellent Patient Outcomes With Or Without Defibrillation Testing

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development -- Research, Prosthesis -- Product development -- Research, Electric countershock -- Research, Implants, Artificial -- Product development -- Research, Medical equipment and supplies industry -- Product development -- Research, Clinical trials -- Research, Cardiac patients -- Patient outcomes -- Research, Defibrillators -- Product development -- Research, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- A Boston Scientific Corporation (NYSE: BSX) study demonstrated that outcomes for patients with the company's transvenous implantable cardioverter defibrillators [...]

Published
2014

20. Boston Scientific Begins Clinical Trial of ACUITY™ X4 LV Pacing Leads and RELIANCE™ 4-FRONT ICD Leads

Subjects
United States. Food and Drug Administration, Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- Boston Scientific Corporation (NYSE: BSX) has conducted the first implant in the clinical trial of the next generation ACUITY™ [...]

Published
2014

21. Taxus Express(2) paclitaxel-eluting coronary stent system

Subjects
Boston Scientific Corp. -- Product development, Taxus Express(2) (Medical instrument) -- Licensing, certification and accreditation, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Stent (Surgery) -- Licensing, certification and accreditation
Abstract

Boston Scientific Corp., Natick, Mass., (888) 272-1001, has the FDA's approval to extend the shelf life of its Taxus Express(2) paclitaxel-eluting coronary stent system to 18 months in the United [...]

Published
2007

22. Cold-hearted remedy

Subjects
Boston Scientific Corp. -- Product development, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Business, Chemicals, plastics and rubber industries
Published
2006

23. Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise DBS System In Treatment Of Parkinson's Disease

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development -- Usage, Direct broadcast satellite television industry -- Product development -- Usage, Extrapyramidal disorders -- Drug therapy -- Usage, Medical equipment and supplies industry -- Product development -- Usage, Clinical trials -- Usage, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- Boston Scientific Corporation (NYSE: BSX) announces the first implantation of its Vercise™ DBS System as part of the INTREPID [...]

Published
2013

24. Presentation of Preliminary Results From Boston Scientific PREVAIL Clinical Trial Now Available

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health, American College of Cardiology
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- Boston Scientific Corporation (NYSE: BSX) announces the preliminary analysis of the PREVAIL clinical trial data is now available on [...]

Published
2013

25. Boston Scientific Updates PREVAIL Late Breaking Clinical Trials Presentation

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- The Boston Scientific Corporation (NYSE: BSX) PREVAIL clinical trial results will be presented in a Late-Breaking Clinical Trial presentation [...]

Published
2013

26. First Patient Treated In The Boston Scientific ZERO AF Clinical Trial To Evaluate The Safety And Performance Of The Blazer[R] Open-Irrigated Temperature Ablation Catheter

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Atrial fibrillation, Ablation (Surgery), Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- The first patient has been treated in the Boston Scientific Corporation (NYSE: BSX) ZERO AF clinical trial to evaluate [...]

Published
2013

27. Taxus Express2

Subjects
United States. Food and Drug Administration -- Standards, Taxus Express2 (Medication) -- Licensing, certification and accreditation, Medical equipment and supplies industry -- Product development, Stent (Surgery) -- Licensing, certification and accreditation, Boston Scientific Corp. -- Product development
Abstract

FDA approved extending the shelf-life of the paclitaxel-eluting coronary stent (Taxus Express2, Boston Scientific) from six months to nine […]

Published
2004

28. The Cardiovascular Research Foundation announces initiation of HORIZONS-AMI II Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Heart attack -- Research, Medical research, Medicine, Experimental, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

CHICAGO, IL - The Cardiovascular Research Foundation (CRF) announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in patients with [...]

Published
2012

29. Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

Subjects
Boston Scientific Corp. -- Product development, Heart attack, Cardiology, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) announces its support of the HORIZONS II AMI clinical trial, which is designed to evaluate the safety and efficacy of the PROMUS Element™ Plus Everolimus-Eluting [...]

Published
2012

30. Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal Stent Deformation With Boston Scientific Platinum Chromium Stents

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) announces results from a quantitative coronary angiographic (QCA) analysis of the incidence of longitudinal stent deformation in the PERSEUS and PLATINUM randomized clinical trials, comprising [...]

Published
2012

31. Boston Scientific Begins Clinical Trial Enrollment for OMEGA Platinum Chromium Stent System

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) has started patient enrollment in the OMEGA clinical trial, designed to evaluate the safety and effectiveness of the Company's OMEGA™ Platinum Chromium Bare-Metal Coronary Stent [...]

Published
2011

32. Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Cardiovascular agents -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Heart failure, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foRHeart Failure) clinical trial. NECTAR-HF is a prospective, randomized, international clinical feasibility study designed [...]

Published
2011

33. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY Drug-Eluting Coronary Stent

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) announced the completion of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Company's fourth-generation SYNERGY™ [...]

Published
2011

34. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Evaluation -- Product development, Medical test kit industry -- Product development, Nickel alloys -- Evaluation -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol Stent System for the [...]

Published
2011

35. Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinson's Disease

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Extrapyramidal disorders, Medical equipment and supplies industry -- Product development, Parkinson's disease, Clinical trials, Health, Parkinson's Disease Foundation
Abstract

Boston Scientific Corporation (NYSE: BSX) announced the first implantation of its Vercise™ Deep Brain Stimulation (DBS) System as part of the VANTAGE clinical trial. VANTAGE is a multi-center, prospective trial [...]

Published
2010

36. Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Angiogenesis inhibitors, Health
Abstract

Boston Scientific Corporation (NYSE:BSX) announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. [...]

Published
2010

37. Boston Scientific Begins Platinum Plus Trial for Promus[R] Element Stent System

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Transition metals, Chromium alloys -- Product development, Health
Abstract

Boston Scientific Corporation (NYSE:BSX) announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research (ISR) study designed to compare the performance of the PROMUS® Element™ Everolimus-Eluting Coronary Stent [...]

Published
2010

38. Boston Scientific Begins Groundbreaking Clinical Trial Comparing Spinal Cord Stimulation to Spine Reoperation In Patients With Failed Back Surgery Syndrome

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Surgery, Health
Abstract

Boston Scientific Corporation (NYSE:BSX) announced the start of patient enrollment in the EVIDENCE Clinical Trial, which compares the therapeutic effectiveness and cost effectiveness of spinal cord stimulation (SCS) therapy to [...]

Published
2010

39. CryoCor, Boston Sci ink deal for AF treatment development

Subjects
CryoCor -- Product development, CryoCor -- Contracts, Boston Scientific Corp. -- Product development, Boston Scientific Corp. -- Contracts, Medical equipment and supplies industry -- Product development, Medical equipment and supplies industry -- Contracts, Medical test kit industry -- Product development, Medical test kit industry -- Contracts, Contract agreement, Biotechnology industry, Business, Business, international
Abstract

Medical Device Daily Washington Editor CryoCor (San Diego) wasted li ttle time in harvesting the fruits of its hard-won approvable recommendation by the FDA circulatory systems advisory panel last week, [...]

Published
2006

40. Problem reported with defibrillators

Subjects
Boston Scientific Corp. -- Product development, Defibrillators -- Usage, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, General interest, News, opinion and commentary
Published
2009

41. Boston Scientific begins worldwide clinical review of its Taxus paclitaxel-eluting stent

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Business, Health care industry
Abstract

In late May, the 400th patient was enrolled in the world's largest drug-eluting stent registry, called the Taxus Liberte registry. Registry members will participate in post-approval clinical trials of the [...]

Published
2005

42. Hospitals hail arrival of second generation of drug-eluting stents; major GPO contracting

Subjects
Boston Scientific Corp. -- Product development, Pharmaceutical industry -- Product development, Stent (Surgery), Business, Health care industry, Taxus Express2 paclitaxel-eluting coronary stent (Medication) -- Licensing, certification and accreditation
Abstract

The choice of drug-eluting stents doubled--and the market finally became competitive--on March 4 with the FDA's approval of the Taxus Express2 paclitaxel-eluting coronary stent from Boston Scientific, Natick, Mass. Taxus [...]

Published
2004

43. Angiotech's technology approved with BSC stent

Subjects
Angiotech Pharmaceuticals Inc. -- Product development, Angiotech Pharmaceuticals Inc. -- Licensing agreements, Angiotech Pharmaceuticals Inc. -- Alliances and partnerships, Boston Scientific Corp. -- Product development, Boston Scientific Corp. -- Licensing agreements, Boston Scientific Corp. -- Alliances and partnerships, Cardiovascular instruments, Implanted -- Licensing, certification and accreditation, Medical equipment and supplies industry -- Product development, Medical equipment and supplies industry -- Licensing agreements, Medical equipment and supplies industry -- Alliances and partnerships, Pharmaceutical industry -- Product development, Pharmaceutical industry -- Licensing agreements, Pharmaceutical industry -- Alliances and partnerships, Company licensing agreement, Biotechnology industry
Abstract

Angiotech Pharmaceuticals Inc. and partner Boston Scientific Corp. received approval March 4 for the Taxus Express2 paclitaxel-eluting coronary stent system. Angiotech, of Vancouver, British Columbia, licensed the coating for the [...]

Published
2004

44. Corautus gets lift from Boston Scientific deal. (Friday, Aug. 1)

Subjects
Boston Scientific Corp. -- Research, Boston Scientific Corp. -- Contracts, Boston Scientific Corp. -- Product development, Corautus Genetics Inc. -- Research, Corautus Genetics Inc. -- Contracts, Corautus Genetics Inc. -- Product development, Medical equipment and supplies industry -- Research, Medical equipment and supplies industry -- Contracts, Medical equipment and supplies industry -- Product development, Drug delivery devices -- Product development, Biotechnology industry -- Contracts, Biotechnology industry -- Research, Biotechnology industry -- Product development, Cardiovascular diseases -- Drug therapy, Biotechnology industry
Abstract

Corautus Genetics Inc. and Boston Scientific Corp. disclosed their alliance to develop a gone delivery technology for the treatment of cardiovascular disease in a deal that has a total potential [...]

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results